This new review article from Wei Ying Jen, Marina Konopleva, & Naveen Pemmaraju, MD is all about #tagraxofusp for #BPDCN . Learn how it is being used in combination to improve outcomes in BPDCN & AML, & its developing role in other hematological malignancies: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

📣 Last call - Register today for a unique opportunity to have your questions answered by leading experts in #PrecisionOncology .
Register now: 🔗ow.ly/m3yo50R9l7r

Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis

30 Posts Not To Miss From AACR 24 !
Dr. Kimryn Rathmell Lynn M. Schuchter, MD, FASCO @ASCO Vivek Subbiah, MD Dr. Patrick Hwu Wafik S. El-Deiry, MD, PhD, FACP Chendi Li d.planchard Harmony Saunders Paolo Tarantino AACR_CEO Jakob Nikolas Kather Nicholas Huntington Pashtoon Kasi MD, MS K Lukasik Christine Lovly, MD, PhD Ivy Riano, M.D. #OncoDaily

oncodaily.com/48590.html

🚀 Explore the frontier of cancer treatment at #PrecisionOncology a not-to-be-missed webinar!
🧬🎯Dive deep into the taxonomy of treatments that are changing lives irrespective of cancer type.
ESMO - Eur. Oncology OncoAlert Vivek Subbiah, MD George Pentheroudakis Ben Westphalen #Oncology

What an amazing panel! Can’t miss this event!

🚨Curious about #Tumour #agnostic treatments? Don't miss out! Join us tomorrow for an illuminating #PrecisionOncology webinar featuring international experts.
👉There's still time to register. See you there! 🌟 ESMO - Eur. Oncology Annals of Oncology
Register now with your ESMO account:…

Let's spread awareness about clinical trials - Michelyn Smith
Sarah Cannon Docs Vivek Subbiah, MD

#Cancer #ClinicalTrials #HealthQuestions #MedicalKnowledge #OncoDaily #Oncology #Cancer Research #Cancer Awareness

oncodaily.com/48845.html

🕰️There is still time to join the #PrecisionOncology webinar and submit your questions to international experts. Register now with your ESMO account: 🔗ow.ly/VSR550R9kee

Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis

I am proud to announce that I have been named an Advocacy Champion at the #ASCOAdvocacy Summit ! This past year I engaged with my local representatives to improve care for patients w #cancer . #ASCOAdvocacy

Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab | Nature Reviews Clinical Oncology nature.com/articles/s4157…

Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers - European Journal of Cancer ejcancer.com/article/S0959-…

📍Such a delight to Chair the Plenary session at AACR #AACR24 last week
✅AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, & Improving Trial Design
✅Thanks to AACR scientific meeting team for the vision for this session on AI.
Thanks to…

An absolute honor to meet the legendary Rick Pazdur at the FDA Oncology! - Vivek Subbiah, MD

#AACR #Cancer #FDAOncology #OncoDaily #Oncology

oncodaily.com/47659.html

AI’s Threat to the Medical Profession JAMA jamanetwork.com/journals/jama/…

Patients Are Turning to TikTok for Health Information—Here’s What Clinicians Need to Know JAMA
jamanetwork.com/journals/jama/…

Thanks a lot for the shout-out Vivek Subbiah, MD, means a lot coming from a key thought leader in #precisiononcology #precisionmedicine !

Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2 | JCO Precision Oncology Jun Gong ascopubs.org/doi/10.1200/PO…

Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1 | JCO Precision Oncology Jun Gong ascopubs.org/doi/10.1200/PO…

Where does the AACR 24 Plenary Chair work with the ASCO Plenary Chair? - Vivek Subbiah, MD

oncodaily.com/48217.html

#oncodaily #AACR24 #ASCO24 #precisionmedicine #rarecancers #genefusions #cancerresearch #oncologyconference